Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Vaccines

Free Subscription Articles published in J Virol Retrieve available abstracts of 120 articles: HTML format

Single Articles

June 2009
1. BAROUCH DH , Liu J, Lynch DM, O'Brien KL, et al
   Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine Against SIV Challenge in Rhesus Monkeys.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. SATHESHKUMAR PS , Weisberg A, Moss B
   Vaccinia Virus H7 Protein Contributes to the Formation of Crescent Membrane Precursors of Immature Virions.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. WANG Y , Flesch IE, Tscharke DC
   Vaccinia virus CD8+ T cell dominance hierarchies cannot be altered by prior immunization with individual peptides.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
4. VAN DER SANDEN S , Pallansch MA, van de Kassteele J, El-Sayed N, et al
   Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. OURMANOV I , Kuwata T, Goeken R, Goldstein S, et al
   Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
   J Virol. 2009;83:5388-400.
   PubMed     Related articles    Abstract available
   
   
   
6. ENQUIST LW
   Virology in the 21st century.
   J Virol. 2009;83:5296-308.
   PubMed     Related articles   
   
   
   May 2009
7. MIDDLETON D , Rockman S, Pearse M, Barr I, et al
   Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunisation.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. SEXTON A , De Rose R, Reece JC, Alcantara S, et al
   Evaluation of recombinant influenza-SIV vaccines in macaques.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. KORBER BT , Letvin NL, Haynes BF
   T cell Vaccine Strategies for HIV, the Virus With a Thousand Faces.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. WYATT LS , Earl PL, Xiao W, Americo JL, et al
    Elucidating and minimizing loss of vaccinia virus recombinant HIV gene expression resulting from spontaneous mutations and positive selection.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. WANG L , Cheng C, Ko SY, Kong WP, et al
    Delivery of adenovirus HIV vaccine vectors to the intestine induces enhanced mucosal cellular immunity.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
12. LEVENBOOK I , Draper K
    Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.
    J Virol. 2009;83:5289-9o.
    PubMed     Related articles   
    
    
    April 2009
13. WILSON NA , Keele BF, Reed JS, Piaskowski SM, et al
    Vaccine-induced Cellular Responses Control SIV Replication After Heterologous Challenge.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
14. HENSLEY SE , Pinto AK, Hickman HD, Kastenmayer RJ, et al
    Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. SOARES JA , Leite FG, Andrade LG, Torres AA, et al
    ACTIVATION OF THE PI3K/Akt PATHWAY EARLY DURING VACCINIA AND COWPOX VIRUS INFECTION IS REQUIRED FOR BOTH HOST SURVIVAL AND VIRAL REPLICATION.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. BELLONE S , El-Sahwi K, Cocco E, Casagrande F, et al
    HPV16 VLP L1-Specific CD8+ Cytotoxic T Lymphocytes (CTL) are equally effective as E7-Specific CD8+ CTL in killing autologous HPV16 Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 dendritic cell-based Therapeutic Vaccines.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. GEISBERT TW , Geisbert JB, Leung A, Daddario-Dicaprio KM, et al
    Single injection vaccine protects nonhuman primates against Marburg virus and three species of Ebola virus.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
18. MYSKIW C , Arsenio J, van Bruggen R, Deschambault Y, et al
    Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of PKR, NF-{kappa}B and IRF3 pathways.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
19. CHING YC , Chung CS, Huang CY, Hsia Y, et al
    Disulfide bond formation at the C-termini of vaccinia A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
20. SPERLING KM , Schwantes A, Staib C, Schnierle BS, et al
    The orthopoxvirus 68k ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in non-permissive human and murine cells.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
21. RODRIGUEZ PULIDO M , Sobrino F, Borrego B, Saiz M, et al
    Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.
    J Virol. 2009;83:3475-85.
    PubMed     Related articles    Abstract available
    
    
    
22. KOUP RA , Lamoreaux L, Zarkowsky D, Bailer RT, et al
    Multiply-deleted replication-defective adenovirus vectors do not induce measurable vector-specific T cells in human trials.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    March 2009
23. WATANABE S , Watanabe T, Kawaoka Y
    Influenza A virus lacking M2 protein as a live attenuated vaccine.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
24. ZHANG P , Langland JO, Jacobs BL, Samuel CE, et al
    Protein Kinase PKR-dependent Activation of Mitogen Activated Protein Kinases occurs through Mitochondrial Adapter IPS-1 and is Antagonized By Vaccinia Virus E3L.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
25. PERRONE LA , Ahmad A, Veguilla V, Lu X, et al
    Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
26. MOOIJ P , Balla-Jhagjhoorsingh SS, Beenhakker N, van Haaften P, et al
    Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding HIV-1 clade C immunogens.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
27. CAYABYAB MJ , Korioth-Schmitz B, Sun Y, Carville A, et al
    Recombinant BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional SIV-specific T cell responses.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
28. MAYRHOFER J , Coulibaly S, Hessel A, Holzer G, et al
    Non-replicating vaccinia vectors expressing the H5 influenza hemagglutinin produced in modified Vero cells induce robust protection.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
29. PICHLA-GOLLON SL , Lin SW, Hensley SE, Lasaro MO, et al
    Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
30. ARNOLD GF , Velasco PK, Holmes AK, Wrin T, et al
    Broad Neutralization of HIV-1 Elicited from Human Rhinoviruses that Display the HIV-1 gp41 ELDKWA Epitope.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    February 2009
31. ZHAO J , Lai L, Amara RR, Montefiori DC, et al
    Preclinical studies on HIV/AIDS vaccines: Inverse correlation between avidity of anti-Env Ab and peak post challenge viremia.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
32. GAMMON DB , Evans DH
    The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
33. TRILLING M , LE VT, Zimmermann A, Ludwig H, et al
    An IFN-{gamma}-Induced IRF-1-Dependent Antiviral Response Inhibits Vaccinia Virus Replication in Mouse but Not Human Fibroblasts.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
34. ZABOROWSKA I , Walsh D
    PI3K signaling regulates rapamycin-insensitive translation initiation complex formation in Vaccinia Virus-infected cells.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
35. QUAN FS , Yoo DG, Song JM, Clements JD, et al
    Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
36. HALFMANN P , Ebihara H, Marzi A, Hatta Y, et al
    Replication-Deficient Ebolavirus as a Vaccine Candidate.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
37. LADDY DJ , Yan J, Khan AS, Anderson H, et al
    Electroporation of Synthetic DNA Antigens Offers Protection in Non-Human Primates Challenged with Highly Pathogenic Avian Influenza.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    January 2009
38. LOBUE AD , Thompson JM, Lindesmith L, Johnston RE, et al
    Alphavirus-adjuvanted Norovirus VLP Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect from Murine Norovirus Challenge.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
39. KARWACZ K , Mukherjee S, Apolonia L, Blundell MP, et al
    Non-integrating Lentivector Vaccines Stimulate Prolonged T Cell and Antibody Responses and are Effective in Tumor Therapy.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
40. LOWEN AC , Steel J, Mubareka S, Carnero E, et al
    Blocking inter-host transmission of influenza virus by vaccination in the guinea pig model.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
41. LEHMANN MH , Kastenmuller W, Kandemir JD, Brandt F, et al
    Modified vaccinia virus Ankara (MVA) triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
42. PASETTI MF , Ramirez K, Resendiz-Albor A, Ulmer J, et al
    Sindbis-virus measles DNA vaccines protect cotton rats against respiratory measles; relevance of antibodies, mucosal and systemic antibody secreting cells, memory B cells and Th1-type cytokines as correlates of immunity.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
43. YAKOVENKO ML , Korotkova EA, Ivanova OE, Eremeeva TP, et al
    Evolution of the Sabin Vaccine into Pathogenic Derivatives without Appreciable Changes in Antigenic Properties: Need for Improvement of Current Poliovirus Surveillance.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
44. SATHESHKUMAR PS , Anton LC, Sanz P, Moss B, et al
    Inhibition of the Ubiquitin-Proteasome System Prevents Vaccinia Virus DNA Replication and Expression of Intermediate and Late Genes.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
45. KONG WP , Wu L, Wallstrom TC, Fischer W, et al
    Expanded Breadth of the T-cell Response to Mosaic HIV-1 Envelope DNA Vaccination.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
46. LOBIGS M , Larena M, Alsharifi M, Lee E, et al
    Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective value against Murray Valley encephalitis virus.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
47. SUZUKI R , Winkelmann ER, Mason PW
    Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
48. WAIBLER Z , Anzaghe M, Frenz T, Schwantes A, et al
    Vaccinia virus-mediated inhibition of type I interferon responses is a multi-factorial process involving the soluble type I interferon receptor B18 and intracellular components.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
49. STEEL J , Lowen AC, Pena L, Angel M, et al
    Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 HPAI.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
50. RAHBAR R , Murooka TT, Fish EN
    A role for CCR5 in dissemination of vaccinia virus in vivo.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
51. PENG Y , Lin FC, Verardi PH, Jones LA, et al
    Lower Levels of IFN-{gamma} Expressed by a Pseudotyped Single-cycle SIV Enhances Immunogenicity in Rats.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
52. JOHNSTON SC , Ward BM
    The Vaccinia Virus Protein F12 Associates with IEV Through an Interaction with A36.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    November 2008
53. WAGENAAR TR , Moss B
    Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
54. ROWE HM , Lopes L, Brown N, Efklidou S, et al
    Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells and increases CD8+ T cell responses.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
55. RAFII-EL-IDRISSI BENHNIA M , McCausland MM, Moyron J, Laudenslager J, et al
    Complement dependence of vaccinia virus extracellular enveloped virion (EV) neutralization in vitro and protection in vivo.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
56. MASON RD , Alcantara S, Peut V, Loh L, et al
    Inactivated SIV-pulsed autologous fresh blood cells as an immunotherapy strategy.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
57. WEI H , Huang D, Fortman J, Wang R, et al
    Cidofovir + Dryvax co-administration reduced Dryvax vaccination side effect but interfered with vaccine-elicited immune responses and anti-monkeypox immunity.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
58. MORNER A , Douagi I, Forsell MN, Sundling C, et al
    HIV-1 Env-trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
59. CARNERO E , Li W, Borderia AV, Moltedo B, et al
    Optimization of HIVGag expression by Newcastle disease virus vectors for the induction of potent immune responses.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
60. VAGVALA SP , Thebeau LG, Wilson SR, Morrison LA, et al
    Virus-encoded B7-2 costimulation molecules enhance the protective capacity of a replication-defective HSV-2 vaccine in immunocompetent mice.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
61. KO SY , Cheng C, Kong WP, Wang L, et al
    Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
62. GENESCA M , Skinner PJ, Hong JJ, Li J, et al
    With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
    J Virol. 2008;82:11181-96.
    PubMed     Related articles    Abstract available
    
    
    
63. TILLIEUX SL , Halsey WS, Thomas ES, Voycik JJ, et al
    Complete DNA sequences of two oka strain varicella-zoster virus genomes.
    J Virol. 2008;82:11023-44.
    PubMed     Related articles    Abstract available
    
    
    October 2008
64. HIDAJAT R , Xiao P, Zhou Q, Venzon D, et al
    Correlation of vaccine-elicited systemic and mucosal non-neutralizing antibody activities with reduced acute viremia following intrarectal SIVmac251 challenge of rhesus macaques.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
65. CHEN Z , Santos C, Aspelund A, Gillim-Ross L, et al
    Evaluation of Live Attenuated Influenza A H6 Vaccines in Mice and Ferrets.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
66. GAMMON DB , Snoeck R, Fiten P, Krecmerova M, et al
    Mechanism of antiviral drug resistance of vaccinia virus: Identification of residues in the viral DNA polymerase conferring differential resistance to anti-poxvirus drugs.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
67. HOWARD AR , Senkevich TG, Moss B
    Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
68. COLLINS PL , Bukreyev A, Murphy BR
    What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?
    J Virol. 2008;82:9805-6.
    PubMed     Related articles   
    
    
    
69. MATEO R , Luna E, Rincon V, Mateu MG, et al
    Engineering Viable Foot-and-Mouth Disease Viruses of Increased Thermostability as a Step in the Development of Improved Vaccines.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
70. LEVINE AJ
    "Why do we not yet have an HIV vaccine?"
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
71. GARAICOECHEA L , Olichon A, Marcoppido G, Wigdorovitz A, et al
    Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.
    J Virol. 2008;82:9753-64.
    PubMed     Related articles    Abstract available
    
    
    September 2008
72. BOWDEN TA , Crispin M, Harvey DJ, Aricescu AR, et al
    Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: A Template for Antiviral and Vaccine Design.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
73. PETRAVIC J , Ribeiro RM, Casimiro DR, Mattapallil JJ, et al
    Estimating the Impact of Vaccination in Acute SHIV/SIV Infection.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
74. TAKEDA M , Ohno S, Tahara M, Takeuchi H, et al
    Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM-knockin mice.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
75. KIM JK , Seiler P, Forrest HL, Khalenkov AM, et al
    Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic Ducks.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
76. MOK H , Tollefson SJ, Podsiad AB, Shepherd BE, et al
    An Alphavirus Replicon-Based Human Metapneumovirus Vaccine is Immunogenic and Protective in Mice and Cotton Rats.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
77. WANG BZ , Quan FS, Kang SM, Bozja J, et al
    Membrane-anchored Flagellin Incorporation into Influenza VLPs Enhances the Breadth of Immune Responses.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
78. MURAKAMI S , Horimoto T, Mai LQ, Nidom CA, et al
    Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
79. HAI R , Martinez-Sobrido L, Fraser KA, Ayllon J, et al
    Influenza B NS1 Truncation Mutant Viruses: A Live-attenuated Vaccine Approach.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
80. AFONSO CL
    Not so fast on recombination analysis of Newcastle disease virus.
    J Virol. 2008;82:9303.
    PubMed     Related articles   
    
    
    
81. AHMED M , Marino TR, Puckett S, Kock ND, et al
    Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
    J Virol. 2008;82:9273-7.
    PubMed     Related articles    Abstract available
    
    
    
82. ODOOM JK , Yunus Z, Dunn G, Minor PD, et al
    Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.
    J Virol. 2008;82:9179-90.
    PubMed     Related articles    Abstract available
    
    
    August 2008
83. YOUN JW , Hu YW, Tricoche N, Pfahler W, et al
    Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
84. DEMBERG T , Boyer JD, Malkevich N, Patterson LJ, et al
    Sequential priming with SIV DNA vaccines, with or without encoded cytokines, and a replicating Ad-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
85. DENG L , Dai P, Parikh T, Cao H, et al
    Vaccinia virus subverts a MAVS-dependent innate immune response in keratinocytes through its dsRNA binding protein E3.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
86. SOOD CL , Ward JM, Moss B
    Vaccinia virus encodes a small hydrophobic virion membrane protein (I5) that enhances replication and virulence in mice.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
87. NICHOLS RJ , Stanitsa E, Unger B, Traktman P, et al
    The vaccinia virus I2L gene encodes a membrane protein with an essential role in virion entry.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
88. IZMAILYAN R , Chang W
    Vaccinia viral protein WR53.5/F14.5 is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
89. LAMIRANDE EW , DeDiego ML, Roberts A, Jackson JP, et al
    A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.
    J Virol. 2008;82:7721-4.
    PubMed     Related articles    Abstract available
    
    
    July 2008
90. KAWADA M , Tsukamoto T, Yamamoto H, Iwamoto N, et al
    Gag-specific cytotoxic T lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
91. VACCARI M , Mattapallil J, Song K, Tsai WP, et al
    Reduced Protection From SIVmac251 Afforded by Memory CD8+ T-cells Induced by Vaccination in Condition of CD4+ T-cell Deficiency.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
92. SHIN EC , Capone S, Cortese R, Colloca S, et al
    The Kinetics of Hepatitis C Virus-Specific CD8 T Cell Responses in the Blood Mirrors Those in the Liver in Acute Hepatitis C Virus Infection.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
93. TERAJIMA M , Cruz J, Leporati AM, Orphin L, et al
    Influenza A Virus Matrix Protein 1-Specific Human CD8+ T Cell Response Induced in Trivalent Inactivated Vaccine Recipients.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
94. BISHT H , Weisberg AS, Moss B
    Vaccinia Virus L1 Protein is Required for Cell Entry and Membrane Fusion.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
95. HAN GZ , Liu XP, Li SS
    Caution about Newcastle disease virus-based live attenuated vaccine.
    J Virol. 2008;82:6782.
    PubMed     Related articles   
    
    
    
96. CUBILLOS C , de la Torre BG, Jakab A, Clementi G, et al
    Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.
    J Virol. 2008;82:7223-30.
    PubMed     Related articles    Abstract available
    
    
    June 2008
97. RIQUET FB , Blanchard C, Jegouic S, Balanant J, et al
    Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
98. SUN Y , Santra S, Schmitz JE, Roederer M, et al
    Magnitude and Quality of Vaccine-elicited T Cell Responses in the Control of Immunodeficiency Virus Replication in Rhesus Monkeys.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. BRITTLE EE , Wang F, Lubinski JM, Bunte RM, et al
    A Replication Competent, Neuronal Spread Defective, Live Attenuated Herpes Simplex Virus Type-1 Vaccine.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
100. HUANG CY , Lu TY, Bair CH, Chang YS, et al
     A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
101. FOGG CN , Americo JL, Earl PL, Resch W, et al
     Disparity between in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice to intranasal challenge.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
102. COX KS , Clair JH, Prokop MT, Sykes KJ, et al
     DNAgag/Ad5gag and Ad5gag/Ad5gag Vaccines Induce Distinct T cell Response Profiles.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
103. ACHDOUT H , Manaster I, Mandelboim O
     Influenza virus infection augments NK cell inhibition through the reorganization of MHC class I proteins.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     May 2008
104. GASPER-SMITH N , Crossman DM, Whitesides JF, Mensali N, et al
     Induction of Plasma (TRAIL), TNFR-2, Fas Ligand and Plasma Microparticles After HIV-1 Transmission: Implications for HIV-1 Vaccine Design.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
105. LIN Y , Kwon T, Polo J, Zhu YF, et al
     The induction of broad CD4+ and CD8+ T cell responses and cross-neutralizing antibodies against the hepatitis C virus (HCV) by vaccinating with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1/
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
106. KUZNETSOV Y , Gershon PD, McPherson A
     Atomic Force Microscopy Investigation of Vaccinia Virus Structure.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
107. SMITH MZ , Asher TE, Venturi V, Davenport MP, et al
     Limited maintenance of vaccine-induced SIV-specific CD8 T cell receptor clonotypes after virus challenge.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
108. VAINE M , Wang S, Crooks ET, Jiang P, et al
     Improved induction of antibodies against key neutralizing epitopes by HIV-1 gp120 DNA prime-protein boost vaccination compared to gp120 protein only vaccination.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
109. JING L , Davies DH, Chong TM, Chun S, et al
     An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T cell profiling.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
110. SUZUKI R , Fayzulin R, Frolov I, Mason PW, et al
     Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: use in safer propagation of a novel vaccine candidate.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. RAVIPRAKASH K , Wang D, Ewing D, Holman DH, et al
     A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys Against All Four Serotypes of Dengue Viruses.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. DAY PM , Gambhira R, Roden RB, Lowy DR, et al
     Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
     J Virol. 2008;82:4638-46.
     PubMed     Related articles    Abstract available
     
     
     April 2008
113. BANSAL A , Jackson B, West K, Wang S, et al
     Multifunctional T cell characteristics induced by a polyvalent DNA prime/protein boost HIV-1 vaccine regimen given to healthy adults are dependant upon the route and dose of administration.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
114. KAUFMAN DR , Goudsmit J, Holterman L, Ewald BA, et al
     Differential Antigen Requirements for Protection Against Systemic and Intranasal Vaccinia Virus Challenges in Mice.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
115. LIN YC , Li J, Irwin CR, Jenkins H, et al
     Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
116. NELSON GE , Wagenaar TR, Moss B
     A Conserved Sequence Within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex is Important for Interaction with the A28 Subunit and Infectivity.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
117. WEI CJ , Xu L, Kong WP, Shi W, et al
     Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
118. LEE E , Lobigs M
     E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impedes virus spread and attenuates virulence.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     March 2008
119. LIU J , Ewald BA, Lynch DM, Denholtz M, et al
     Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     February 2008
120. RAVIV Y , Blumenthal R, Tompkins SM, Humberd J, et al
     Hydrophobic Inactivation of Influenza Viruses confers Preservation of Viral Structure with Enhanced Immunogenicity.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: